Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
June 28, 2023 04:00 ET
|
AKAMPION
- First-in-human clinical trial of MyopiaX®, the first therapeutic approach in juvenile myopia to target the dopamine pathway digitally- Enrollment ongoing in Germany, Spain, the Netherlands, and the...
Europe Eye Care Market Report 2023: Featuring Novartis, Essilor International, F.Hoffmann-La Roche, Allergan & More
May 15, 2023 07:33 ET
|
Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Europe Eye Care Market By Product Type (Eyeglasses, Contact Lens, Intraocular Lens, Eye Drops, Others), By Coating (Anti-Glare, Anti reflecting,...
Contact Lens Solutions Global Market to Reach $3.5 Billion by 2030: Hydrogen Peroxide-based Solutions Gain Preference Owing to Their Higher Disinfection Capability
March 21, 2023 13:05 ET
|
Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Contact Lens Solutions: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Contact...
Dopavision Appoints Prof. Dr. Jens Ellrich as Chief Scientific Officer
March 21, 2023 05:00 ET
|
AKAMPION
- Leading translational medicine and neuroscience expert to head Dopavision’s research activities Berlin, Germany, March 21, 2023 --- Dopavision, a clinical-stage company pioneering the...
Global Myopia & Presbyopia Treatment Market 2022 to 2027: Emerging Developments with Introduction of Advanced Lenses Such as Implantable Contact Lenses Presents Opportunities
February 27, 2023 07:58 ET
|
Research and Markets
Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Myopia & Presbyopia Treatment Market (2022-2027) by Treatment, Indication, and Geography, Competitive Analysis and the Impact of Covid-19...
Night Contact Lenses Market to Reach a Revenue of Around US$ 1.8 Billion by the End of 2032 at a CAGR of 7.5%: Study by Persistence Market Research
February 23, 2023 08:00 ET
|
Persistence Market Research
New York, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The Night Contact Lenses Market is at US$ 880.3 Million in 2022 and is expected to increase at a CAGR of 7.5% over the forecast period (2023-2032). Key...
Soft Contact Lens Global Market to Reach $24.8 billion by 2030: Growing Prevalence of Eye Disorders Steers Growth
February 17, 2023 07:43 ET
|
Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Soft Contact Lens: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Soft Contact...
Worldwide Anti-blue Ray Myopia Lenses Industry to 2028: Purchasing High-quality Item for Eye Protection Drives Growth
February 07, 2023 13:03 ET
|
Research and Markets
Dublin, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The "Anti-blue Ray Myopia Lenses Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ...
Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas
January 31, 2023 09:00 ET
|
Eyenovia
LAS VEGAS, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in connection with its...
Vyluma to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023 07:00 ET
|
Vyluma, Inc.
BRIDGEWATER, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing multiple assets for the treatment of refractive errors, today announced it...